MSAM
PACB icon

Moloney Securities Asset Management’s Pacific Biosciences PACB Stock Holding History

Moloney Securities Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$17.9K Buy
+14,000
New +$19K ﹤0.01% 484
2025
Q1 		– Sell
-41,000
Closed -$75K – 512
2024
Q4 		$75K Sell
41,000
-26,200
-39% -$51.1K 0.01% 444
2024
Q3 		$114K Sell
67,200
-85,500
-56% -$140K 0.02% 455
2024
Q2 		$209K Sell
152,700
-12,000
-7% -$24.2K 0.03% 417
2024
Q1 		$618K Buy
+164,700
New +$964K 0.09% 231
2021
Q1 		– Sell
-61,440
Closed -$1.59M – 424
2020
Q4 		$1.59M Sell
61,440
-16,310
-21% -$277K 0.35% 78
2020
Q3 		$767K Sell
77,750
-11,750
-13% -$67.6K 0.2% 128
2020
Q2 		$309K Buy
89,500
+65,400
+271% +$223K 0.09% 224
2020
Q1 		$74K Sell
24,100
-6,400
-21% -$26.2K 0.03% 265
2019
Q4 		$157K Sell
30,500
-4,500
-13% -$22.9K 0.05% 330
2019
Q3 		$181K Buy
+35,000
New +$196K 0.06% 302
2019
Q2 		– Sell
-121,890
Closed -$881K – 334
2019
Q1 		$881K Sell
121,890
-65,034
-35% -$470K 0.3% 105
2018
Q4 		$1.38M Sell
186,924
-281,037
-60% -$1.78M 0.57% 44
2018
Q3 		$2.53M Buy
467,961
+39,500
+9% +$169K 0.88% 22
2018
Q2 		$1.52M Sell
428,461
-26,210
-6% -$72.7K 0.58% 46
2018
Q1 		$932K Buy
454,671
+396,271
+679% +$1.03M 0.38% 87
2017
Q4 		$154K Buy
+58,400
New +$204K 0.06% 247
2017
Q1 		– Sell
-33,600
Closed -$128K – 248
2016
Q4 		$128K Buy
+33,600
New +$244K 0.08% 210

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Moloney Securities Asset Management's PACB Position: Q3 2025 in Review

Moloney Securities Asset Management opened a new position in Pacific Biosciences (PACB) in Q3 2025: 14,000 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #484 among its holdings. This is a return to the name: Moloney Securities Asset Management previously reported a position in PACB as recently as Q4 2024.

Moloney Securities Asset Management first reported a position in PACB in Q4 2016 and has held it in 18 quarters since. The position peaked at $2.53M in Q3 2018. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • Moloney Securities Asset Management held 14,000 shares of Pacific Biosciences worth $17.9K as of Q3 2025.
  • Pacific Biosciences was a new Moloney Securities Asset Management position in Q3 2025.
  • Pacific Biosciences made up ﹤0.01% of Moloney Securities Asset Management's portfolio in Q3 2025, its #484 holding.
  • Moloney Securities Asset Management first reported a position in Pacific Biosciences in Q4 2016 and has held it in 18 quarters since.
  • Moloney Securities Asset Management's Pacific Biosciences position peaked at $2.53M in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.